These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats. Tjurmina OA; Goldstein DS; Palkovits M; Kopin IJ Brain Res; 1999 May; 826(2):243-52. PubMed ID: 10224302 [TBL] [Abstract][Full Text] [Related]
24. Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats. Szemeredi K; Komoly S; Kopin IJ; Bagdy G; Keiser HR; Goldstein DS Brain Res; 1991 Feb; 542(1):8-14. PubMed ID: 2054662 [TBL] [Abstract][Full Text] [Related]
25. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Asnis GM; Wetzler S; Sanderson WC; Kahn RS; van Praag HM Psychiatry Res; 1992 Jul; 43(1):65-76. PubMed ID: 1438618 [TBL] [Abstract][Full Text] [Related]
26. Indices of noradrenergic output in depression. Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600 [TBL] [Abstract][Full Text] [Related]
27. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Charney DS; Heninger GR Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014 [TBL] [Abstract][Full Text] [Related]
28. Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine. Rasmusson AM; Southwick SM; Hauger RL; Charney DS Neuropsychopharmacology; 1998 Jul; 19(1):95-8. PubMed ID: 9608581 [TBL] [Abstract][Full Text] [Related]
29. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. Goldstein DS; Eisenhofer G; Stull R; Folio CJ; Keiser HR; Kopin IJ J Clin Invest; 1988 Jan; 81(1):213-20. PubMed ID: 3335637 [TBL] [Abstract][Full Text] [Related]
30. Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal. Braune S; Albus M; Fröhler M; Höhn T; Scheibe G Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):86-92. PubMed ID: 7948059 [TBL] [Abstract][Full Text] [Related]
32. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment. Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268 [TBL] [Abstract][Full Text] [Related]
33. Plasma-free and sulfoconjugated MHPG in major depressive disorders: differences between responders to treatment and nonresponders. Mine K; Okada M; Mishima N; Fujiwara M; Nakagawa T Biol Psychiatry; 1993 Nov; 34(9):654-60. PubMed ID: 8292695 [TBL] [Abstract][Full Text] [Related]
34. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Charney DS; Woods SW; Heninger GR Psychiatry Res; 1989 Feb; 27(2):173-82. PubMed ID: 2540501 [TBL] [Abstract][Full Text] [Related]
35. Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans. Peskind ER; Veith RC; Dorsa DM; Gumbrecht G; Raskind MA Neuroendocrinology; 1989 Sep; 50(3):286-91. PubMed ID: 2552342 [TBL] [Abstract][Full Text] [Related]
36. Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. Southwick SM; Davis M; Horner B; Cahill L; Morgan CA; Gold PE; Bremner JD; Charney DC Am J Psychiatry; 2002 Aug; 159(8):1420-2. PubMed ID: 12153837 [TBL] [Abstract][Full Text] [Related]
37. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Raskind MA; Peskind ER; Holmes C; Goldstein DS Biol Psychiatry; 1999 Sep; 46(6):756-65. PubMed ID: 10494443 [TBL] [Abstract][Full Text] [Related]
38. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Charney DS; Heninger GR; Sternberg DE Life Sci; 1982 Jun; 30(23):2033-41. PubMed ID: 6287139 [TBL] [Abstract][Full Text] [Related]
39. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548 [TBL] [Abstract][Full Text] [Related]
40. Increase in renal medullary nitric oxide synthase activity protects from norepinephrine-induced hypertension. Szentiványi M; Zou AP; Maeda CY; Mattson DL; Cowley AW Hypertension; 2000 Jan; 35(1 Pt 2):418-23. PubMed ID: 10642335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]